Maura Dougherty
Overview
Explore the profile of Maura Dougherty including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
0
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Combs J, Yamasaki M, Dougherty M, Hunkler K, Osmundsen E, Roura-Monllor J, et al.
Fertil Steril
. 2025 Jan;
PMID: 39848421
Objective: To compare the cost-effectiveness of a gestational carrier (GC) to a uterine transplantation (UTX) in the treatment of absolute uterine-factor infertility. Design: We performed a cost-effectiveness analysis using a...
2.
Ruppel H, Dougherty M, Kodavati M, Lasater K
Nurs Outlook
. 2024 Oct;
72(6):102288.
PMID: 39413565
Background: Alarms pervade the hospital environment, often increasing nurses' workload. Hospital nurses are experiencing burnout at unprecedented rates. Puropse: This study examined the association between nurses' experience of alarms and...
3.
Ruppel H, Dougherty M, Bonafide C, Lasater K
BMJ Open Qual
. 2023 Oct;
12(4).
PMID: 37880160
Background: High rates of medical device alarms in hospitals are a well-documented threat to patient safety. Little is known about organisational features that may be associated with nurses' experience of...
4.
Combs J, Dougherty M, Yamasaki M, DeCherney A, Devine K, Hill M, et al.
F S Rep
. 2023 Sep;
4(3):300-307.
PMID: 37719105
Objective: To evaluate the cost-effectiveness of in vitro fertilization with preimplantation genetic testing for monogenic disease (IVF + PGT-M) in the conception of a nonsickle cell disease (non-SCD) individual compared...
5.
Yoo M, Nelson R, Haaland B, Dougherty M, Cutshall Z, Kohli R, et al.
J Natl Cancer Inst
. 2023 Jul;
115(11):1374-1382.
PMID: 37436697
Background: Recently, several new treatment regimens have been approved for treating metastatic hormone-sensitive prostate cancer, building on androgen deprivation therapy alone. These include docetaxel androgen deprivation therapy, abiraterone acetate-prednisone androgen...
6.
Yoo M, Nelson R, Cutshall Z, Dougherty M, Kohli M
JCO Oncol Pract
. 2023 Jan;
19(3):e449-e456.
PMID: 36599117
Purpose: Several new treatment combinations have been approved in metastatic renal cell carcinoma (mRCC). To determine the optimal therapy on the basis of cost and health outcomes, we performed a...